Analysis of Foxo1-regulated genes using Foxo1-deficient pancreatic β cells. 2012

Satsuki Miyazaki, and Rie Minamida, and Tatsuo Furuyama, and Fumi Tashiro, and Eiji Yamato, and Shinobu Inagaki, and Jun-ichi Miyazaki
Division of Stem Cell Regulation Research, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.

Several reports have suggested that Foxo1, a key regulator in differentiation, growth and metabolism, is involved in pancreatic β-cell function. However, detailed analyses have been hampered by a lack of Foxo1-deficient β cells. To elucidate Foxo1's function in β cells, we produced a β-cell line with inducible Foxo1 deletion. We generated a conditional knockout mouse line, in which Cre recombinase deletes the Foxo1 gene. We then established a β-cell line from an insulinoma induced in this knockout mouse by the β-cell-specific expression of simian virus 40 T antigen. In this cell line, designated MIN6-Foxo1flox/flox, adenovirus-mediated Cre expression ablates the Foxo1 gene, generating MIN6-Foxo1-KO cells. Using these knockout and floxed cell lines, we found that Foxo1 ablation enhanced the glucose-stimulated insulin secretion (GSIS) at high glucose concentrations and enhanced β-cell proliferation. We also conducted DNA microarray analyses of MIN6-Foxo1-KO cells infected with either an adenovirus vector expressing a constitutively active FOXO1 or a control vector and identified several Foxo1-regulated genes, including some known to be related to β-cell function. These cells should be useful for further studies on Foxo1's roles in β-cells and may lead to novel strategies for treating the impaired insulin secretion in type 2 diabetes mellitus.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002678 Chimera An individual that contains cell populations derived from different zygotes. Hybrids,Chimeras,Hybrid
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000071161 Forkhead Box Protein O1 A forkhead box transcription factor that is a major target of INSULIN signaling and regulator of metabolic homeostasis in response to OXIDATIVE STRESS. It binds to the insulin RESPONSE ELEMENT (IRE) and the related Daf-16 family binding element (DBE). Its activity is suppressed by insulin and it also regulates OSTEOBLAST proliferation, controls bone mass, and skeletal regulation of GLUCOSE metabolism. It promotes GLUCONEOGENESIS in HEPATOCYTES and regulates gene expression in ADIPOSE TISSUE. It is also an important CELL DEATH regulator. Chromosomal aberrations involving the FOXO1 gene occur in RHABDOMYOSARCOMA. FOXO1 Protein,Forkhead in Rhabdomyosarcoma Protein

Related Publications

Satsuki Miyazaki, and Rie Minamida, and Tatsuo Furuyama, and Fumi Tashiro, and Eiji Yamato, and Shinobu Inagaki, and Jun-ichi Miyazaki
April 2019, Journal of experimental & clinical cancer research : CR,
Satsuki Miyazaki, and Rie Minamida, and Tatsuo Furuyama, and Fumi Tashiro, and Eiji Yamato, and Shinobu Inagaki, and Jun-ichi Miyazaki
April 2022, Cellular signalling,
Satsuki Miyazaki, and Rie Minamida, and Tatsuo Furuyama, and Fumi Tashiro, and Eiji Yamato, and Shinobu Inagaki, and Jun-ichi Miyazaki
November 2020, Stem cell research & therapy,
Satsuki Miyazaki, and Rie Minamida, and Tatsuo Furuyama, and Fumi Tashiro, and Eiji Yamato, and Shinobu Inagaki, and Jun-ichi Miyazaki
January 2019, American journal of translational research,
Satsuki Miyazaki, and Rie Minamida, and Tatsuo Furuyama, and Fumi Tashiro, and Eiji Yamato, and Shinobu Inagaki, and Jun-ichi Miyazaki
January 2015, Journal of diabetes research,
Satsuki Miyazaki, and Rie Minamida, and Tatsuo Furuyama, and Fumi Tashiro, and Eiji Yamato, and Shinobu Inagaki, and Jun-ichi Miyazaki
September 2007, Molecular endocrinology (Baltimore, Md.),
Satsuki Miyazaki, and Rie Minamida, and Tatsuo Furuyama, and Fumi Tashiro, and Eiji Yamato, and Shinobu Inagaki, and Jun-ichi Miyazaki
August 2019, Oncology letters,
Satsuki Miyazaki, and Rie Minamida, and Tatsuo Furuyama, and Fumi Tashiro, and Eiji Yamato, and Shinobu Inagaki, and Jun-ichi Miyazaki
May 2011, Endocrinology,
Satsuki Miyazaki, and Rie Minamida, and Tatsuo Furuyama, and Fumi Tashiro, and Eiji Yamato, and Shinobu Inagaki, and Jun-ichi Miyazaki
February 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Satsuki Miyazaki, and Rie Minamida, and Tatsuo Furuyama, and Fumi Tashiro, and Eiji Yamato, and Shinobu Inagaki, and Jun-ichi Miyazaki
October 2019, Biochimica et biophysica acta. Molecular basis of disease,
Copied contents to your clipboard!